– Lauxera Capital Partners closed its Lauxera Growth II fund at €520 million, exceeding its €500 million hard cap.
– The fund nearly doubles the size of Lauxera’s first fund and was finalized less than 18 months after its first closing.
– The fund was oversubscribed, with strong backing from returning and new Limited Partners. By
– Lauxera expanded its investor base into the DACH and Nordic regions, Latin America, and the United States.
– The firm focuses on growth-buyout and growth equity investments in innovative Healthtech companies.
– Lauxera aims to help European Healthtech companies scale internationally, especially into the U.S. market.
– Lauxera Growth II plans to invest in 12 to 15 companies.
– Individual investments will range from €20 million to €50 million.
– The fund will take both minority and majority stakes.
– Two investments have already been completed.
– Lauxera operates from both Paris and San Francisco, providing a transatlantic platform for portfolio companies.
– Samuel Levy, Co-Founding Partner at Lauxera Capital Partners, said the firm is grateful for the support of returning and new investors, highlighting the fund’s strong re-up rate and international expansion of its LP base.
– Alex Slack,Co-Founding Partner at Lauxera Capital Partners, said the U.S. remains the most attractive market for scaling European Healthtech companies and emphasized Lauxera’s role in helping founders leverage European innovation strengths to drive growth internationally.
